Biden to launch ‘long-form’ Moonshot

From: POLITICO Pulse - Tuesday Feb 01,2022 03:02 pm
Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Feb 01, 2022 View in browser
 
POLITICO's Pulse newsletter logo

By Sarah Owermohle

Presented by

PhRMA

With Alice Miranda Ollstein, Adam Cancryn and Megan Messerly 

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories.  Act on the news with POLITICO Pro.

QUICK FIX

— The president is taking a long-term view of cancer prevention with a new Moonshot initiative.

— Medical boards are struggling to control misinformation within their ranks as some states fight efforts to sanction those doctors.

— House Republicans add to pressure on HHS Sec. Xavier Becerra after a string of articles about White House frustrations.

WELCOME TO TUESDAY PULSE Wordle users everywhere are split: What is a five-letter word for paywall? Send tips and your starting Wordle words to sowermohle@politico.com.

 

A message from PhRMA:

Washington is talking about price setting of medicines, but it won’t stop insurers from shifting costs to you. And it will risk access to medicines and future cures. Instead, let’s cap your out-of-pocket costs, stop middlemen from pocketing your discounts and make insurance work for you. Let’s protect patients. It’s the right choice. Learn more.

 
Driving the Day

BIDEN TO REVAMP CANCER MOONSHOT WITH LONG-TERM GOALS — President Joe Biden on Wednesday will relaunch his longtime passion project that focuses on cancer prevention, screening and coordination, six people familiar with the project and internal discussion tell PULSE.

The new “Moonshot long-form” will include objectives that weren’t doable when then-vice president Biden unveiled the initiative in the final days of the Obama presidency — but they could be with Biden in office for three more years, said one person familiar. “Now you can start messaging, prevention and screening, nutrition, a focus on disparities,” the person said.

But the relaunch isn’t coming with new funding commitments, even though the Moonshot is down to one year left on the $1.8 billion budget allotted in the 21st Century Cures Act. It’s also unclear how the White House will commandeer interagency coordination on intersecting issues of nutrition, racial disparities and cancer prevention; the original Moonshot initially enlisted 20 agencies from the National Cancer Institute to the Department of Defense.

It’s a deeply held priority for Biden, who unveiled the original plan during an emotional 2015 Rose Garden speech where, citing his son Beau’s death from brain cancer earlier in the year, he announced he would not be running for president.

“If I could be anything, I would have wanted to have been the president that ended cancer, because it’s possible,” Biden said.

Right now: The revamp comes amid uncertainty around the future of yet another broad medical proposal, the Advanced Research Projects Agency for Health . Seen as a Moonshot successor that would tackle some of the world’s most challenging diseases, the $6.5 billion proposed agency languishes in Congress without a vote as lawmakers wrangle over other key Biden agenda items such as the Build Back Better Act.

Longtime NIH Director Francis Collins, a vocal ARPA-H advocate, also stepped down in December, leaving a vacuum for the president to fill at the top of the agency as it steers billions of dollars in medical research, including coronavirus studies and existing cancer work.

REGULATORS SWAMPED BY MEDICAL MISINFO — Medical boards and other regulators across the country are scrambling to penalize doctors who spread misinformation about vaccines or promote unproven cures for Covid-19. But they’re unsure whether they can overcome actions by state lawmakers who believe the boards are overreaching, POLITICO’s Darius Tahir writes.

What’s happening: In all, medical boards have sanctioned eight physicians since January 2021 over coronavirus-related misinformation. Those disciplines — from suspension to revocation of licenses — represent a surprising figure given that the state boards’ processes can take a long time, and often deliver results out of the public eye.

And more sanctions are likely to come. But in some cases, the responses from some medical boards and state officials have been stymied by political backlash. States like Tennessee and North Dakota, for example, have restricted state medical boards’ powers. And now legislators in 10 other states — including Florida and South Carolina — have introduced similar measures.

Misinformation hasn’t just distorted the outlook on vaccines, regulators warn. It’s also helped create a market for unproven drugs and treatment against Covid-19, sometimes with harmful side effects. Poison control centers have recorded increased numbers of calls related to ivermectin and oleandrin, and some patients have been hospitalized after using the drugs.

Under pressure from the flood of misinformation and the anti-establishment mood in many red states, the regulatory structure that upholds professional standards is “unraveling,” warned Richard Baron, the leader of the American Board of Internal Medicine, one of the private-sector bodies that certifies doctors.

“We’re trying to figure out the most effective way to act,” Baron said, conceding he was uncertain about the most effective way to confront the problem. “There are major backlashes. You want to make sure you're on solid ground.”

FIRST IN PULSE: HOUSE Rs QUESTION BECERRA ON LEADERSHIP — The top Republicans on several House committees and subcommittees with pandemic response oversight wrote to HHS Secretary Xavier Becerra yesterday demanding information about his work since being confirmed last year, including details of his visits to various subagencies, the White House and his home state of California.

The letter from Rep. Cathy McMorris Rodgers (R-Wash.), Rep. Brett Guthrie (R-Ky.) and Rep. Morgan Griffith (R-Va.) asks Becerra to respond to a slate of recent news articles critical of his “low-profile” during the Covid-19 pandemic, including his lack of regular press briefings and dearth of in-person meetings with President Biden and other White House officials, Alice writes.

“It appears your leadership has largely been missing, which is particularly concerning given the administration’s careless response to the COVID-19 pandemic,” the lawmakers wrote. They asked Becerra to respond by Feb. 15.

In Congress

LAWMAKERS LAUNCH BIPARTISAN BILL TO SHORE UP STOCKPILERepresentatives led by New Jersey Democrat Josh Gottheimer and North Carolina Republican Richard Hudson on Monday introduced the Medical and Health Stockpile Accountability Act, H.R. 6520, aiming at bolstering medical supply chains in the wake of early pandemic shortages.

The bill would establish new tracking systems for critical supplies like masks, gowns and ventilators and encourage easy and open sharing of that data so states could find out in real time where critical supplies are and who needs them. It would also establish an HHS program to help local and private health providers link easily with vendors.

“It was very clear that we had to figure out a new way for taking stock and inventory not just at the strategic stockpile, but also in our hospitals and other medical centers to understand what was where,” Gottheimer told PULSE, describing early supply shortages in his Northern New Jersey district.

Gottheimer told PULSE he doesn’t think the bill would require more funding despite big data goals — just a moving around of existing resources in HHS.

 

A message from PhRMA:

Advertisement Image

 
Around the Nation

CALIFORNIA’S SINGLE PAYER BILL DIES — Legislation to create what would be the nation’s first government-funded, state-run health care system failed to get a vote Monday on the state’s Assembly floor, effectively ending the push for single-payer this session.

The stakes: The political repercussions of upending California’s health care system were hard to overstate, POLITICO’s Victoria Colliver writes. The stakes were especially high given that Gov. Gavin Newsom, who campaigned for governor on the promise of single-payer, has been notably uninterested in the bill. Newsom has instead been touting his proposal to extend Medi-Cal to all income-eligible undocumented adults.

AB 1400, sponsored by the California Nurses Association, would have all but eliminated private health care and replaced it with a centralized state-run financing system known as CalCare, a plan that legislative analysts estimated could cost between $314 billion and $391 billion a year.

The California Medical Association, the California Association of Health Plans, the California Hospital Association, the California Chamber of Commerce and numerous other business and medical forces had joined to lobby against the bill.

MORE STATES PLEA FOR VACCINE WAIVER Virginia Gov. Glenn Youngkin and West Virginia Gov. Jim Justice are asking CMS to waive the federal health care worker vaccine mandate for rural and state-run facilities, facing what they describe as an “urgent staffing crisis that we believe necessitates relief.”

The Republican governors, in a Monday letter to CMS Administrator Chiquita Brooks-LaSure, acknowledged the Supreme Court’s decision to uphold the mandate but argued their dire staffing needs demanded an exemption.

Some hospitals are “at a breaking point” as a result of the Omicron surge, and “the federal rule is making the problem worse,” the governors wrote. They asked CMS to grant a limited waiver for rural and state-run facilities that could, among other things, delay the rule for six months or provide enforcement flexibility.

Their letter arrives after Montana Republicans last week issued a similar plea, citing dire rural staffing shortages.

Names in the News

Trump HHS Secretary Alex Azar is now working with Foresite Capital, The Washington Post’s Dan Diamond reported Monday . Azar is a part-time consultant with the venture capital firm, which has invested in coronavirus treatments and vaccines.

Juliana Reed is the Biosimilars Forum’s new executive director . Reed most recently was president for the Forum and previously worked for Pfizer, Hospira and Coherus BioSciences.

What We're Reading

Coverage gains seen during the pandemic could soon drop as federal subsidies expire and states restart automatically removing people from Medicaid enrollment, re-adding barriers to keep health insurance, Adrianna McIntyre and Mark Shepard write in an NEJM Perspective.

Coronavirus vaccines for children younger than 5 years old could be available by the end of February , The Washington Post’s Laurie McGinley, Lena Sun and Carolyn Johnson report.

Within Trump’s circles is a growing sense that encouraging vaccines too aggressively could carry political risks — and the former president has stepped off his calls, writes Meridith McGraw in POLITICO.

 

A message from PhRMA:

Washington is talking about price setting of medicines, but it won’t stop insurers from shifting costs to you. And it will risk access to medicines and future cures. Instead, let’s cap your out-of-pocket costs, stop middlemen from pocketing your discounts and make insurance work for you. Let’s protect patients. It’s the right choice. Learn more.

 
 

Follow us on Twitter

Adriel Bettelheim @abettel

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

Erin Banco @ErinBanco

Katherine Ellen Foley @katherineefoley

Lauren Gardner @Gardner_LM

Ben Leonard @_BenLeonard_

Rachael Levy @rachael_levy

David Lim @davidalim

Megan Messerly @meganmesserly

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Darius Tahir @dariustahir

Megan R. Wilson @misswilson

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse

Jan 27,2022 03:02 pm - Thursday

Breyer’s retirement sets high Senate stakes

Jan 25,2022 03:02 pm - Tuesday

Biden pleas for BBB

Jan 24,2022 03:02 pm - Monday

Rethinking our approach to a pandemic

Jan 20,2022 03:22 pm - Thursday

Biden keeps the faith on Covid

Jan 19,2022 03:02 pm - Wednesday

Biden’s home test-delivery site is here